RT Journal Article
SR Electronic
T1 Value of radiomics features from adrenal gland and periadrenal fat CT images predicting COVID-19 progression
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.03.21249183
DO 10.1101/2021.01.03.21249183
A1 Zhang, Mudan
A1 Yin, Xuntao
A1 Li, Wuchao
A1 Zha, Yan
A1 Zeng, Xianchun
A1 Zhang, Xiaoyong
A1 Cui, Jingjing
A1 Tian, Jie
A1 Wang, Rongpin
A1 Liu, Chen
YR 2021
UL http://medrxiv.org/content/early/2021/01/05/2021.01.03.21249183.abstract
AB Background Value of radiomics features from the adrenal gland and periadrenal fat CT images for predicting disease progression in patients with COVID-19 has not been studied.Methods A total of 1,245 patients (685 moderate and 560 severe patients) were enrolled in a retrospective study. We proposed 3D V-Net to segment adrenal glands in onset CT images automatically, and periadrenal fat was obtained using inflation operation around the adrenal gland. Next, we built a clinical model (CM), three radiomics models (adrenal gland model [AM], periadrenal fat model [PM], and fusion of adrenal gland and periadrenal fat model [FM]), and radiomics nomogram (RN) after radiomics features extracted to predict disease progression in patients with COVID-19.Results The auto-segmentation framework yielded a dice value of 0.79 in the training set. CM, AM, PM, FM, and RN obtained AUCs of 0.712, 0.692, 0.763, 0.791, and 0.806, respectively in the training set. FM and RN had better predictive efficacy than CM (P < 0.0001) in the training set. RN showed that there was no significant difference in the validation set (mean absolute error [MAE] = 0.04) and test set (MAE = 0.075) between predictive and actual results. Decision curve analysis showed that if the threshold probability was more than 0.3 in the validation set or between 0.4 and 0.8 in the test set, it could gain more net benefits using RN than FM and CM.Conclusion Radiomics features extracted from the adrenal gland and periadrenal fat CT images may predict progression in patients with COVID-19.Funding This study was funded by Science and Technology Foundation of Guizhou Province (QKHZC [2020]4Y002, QKHPTRC [2019]5803), the Guiyang Science and Technology Project (ZKXM [2020]4), Guizhou Science and Technology Department Key Lab. Project (QKF [2017]25), Beijing Medical and Health Foundation (YWJKJJHKYJJ-B20261CS) and the special fund for basic Research Operating Expenses of public welfare research institutes at the central level from Chinese Academy of Medical Sciences (2019PT320003).Competing Interest StatementThe authors have declared no competing interest.Clinical Trial2020, NO.01Funding StatementThis study was supported Science and Technology Foundation of Guizhou Province (QKHZC[2020]4Y002,QKHPTRC[2019]5803), the Guiyang Science and Technology Project (ZKXM[2020]4), Guizhou Science and Technology Department Key Lab. Project (QKF[2017]25), Beijing Medical and Health Foundation (YWJKJJHKYJJ-B20261CS) and Special Fund for basic Research Operating Expenses of public welfare research institutes at the central level of Chinese Academy of Medical Sciences (2019PT320003).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This multicenter study was approved by the ethics committees of Guizhou Provincial People' s Hospital (2020, NO. 01).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe database used and/or analysed during the current study are available from the corresponding author on reasonable request.